Ruby Dhar

National Institute of Technology Durgapur

H指数:15

被引数:1,268

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microphysiological Systems: Transforming Biomedical and Clinical Research

微生理系统：改变生物医学和临床研究

Biotechnology and Bioengineering

IF3.6

2026-05-060

PRE

miRNA-mRNA network analysis reveals novel post-transcriptional regulators and therapeutic targets in coronary artery disease

miRNA-mRNA网络分析揭示了冠状动脉疾病中新的转录后调控因子和潜在治疗靶点

Journal of Applied Genetics

IF1.9

2026-05-010

PRE

The placental battlefield: viral strategies and immune countermeasures

胎盘战场：病毒策略与免疫对策

Frontiers in Immunology

IF5.9

2025-12-170

OAAI

Evaluating the clinical utility of placental specific beta-1 glycoproteins(PSG) as a novel biomarker for pre-eclampsia

评估胎盘特异性β-1糖蛋白(PSG)作为子痫前期新型生物标志物的临床应用价值

Placenta

IF2.5

2025-11-140

PRE

Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation

探究ACKR1与c-Myc在乳腺癌肿瘤微环境调控中的相互作用

Discover Oncology

IF2.9

2025-08-250

OAAI

Next-Generation models of Gallbladder Carcinoma: Linking biological insights to precision medicine

下一代胆囊癌模型：连接生物学见解与精准医学

critical reviews in oncology hematology

IF0

2025-07-010

PRE

Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance

免疫检查点抑制剂和免疫抑制性肿瘤微环境：当前挑战及克服耐药性的策略

Immunopharmacology and Immunotoxicology

IF3

2025-06-050

PRE

MicroRNA nanoformulation: a promising approach to anti-tumour activity

MicroRNA纳米制剂：一种有前景的抗肿瘤活性方法

INVESTIGATIONAL NEW DRUGS

IF2.7

2025-05-140

PRE

Role of AI in empowering and redefining the oncology care landscape: perspective from a developing nation

FRONTIERS IN DIGITAL HEALTH

IF3.8

2025-03-040

OAAI

Looking beyond the ER, PR, and HER2: what's new in the ARsenal for combating breast cancer?

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY

IF4.7

2025-01-200

OAAI

Aberrant expression of solute carrier family transporters in placentas associated with pregnancy complications

PLACENTA

IF2.5

2025-01-011

PRE

Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer

BMC CANCER

IF3.4

2024-11-133

OAAI

SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies

FRONTIERS IN ONCOLOGY

IF3.3

2024-03-154

OAAI

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms

BMC CANCER

IF3.4

2023-10-263

OAAI

Fenofibrate mediated activation of PPARα negatively regulates trophoblast invasion

PLACENTA

IF2.5

2022-08-014

PRE

The metabolic addiction of cancer stem cells

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-2511

OAAI

Oxidative stress-induced impairment of trophoblast function causes preeclampsia through the unfolded protein response pathway

氧化应激诱导的滋养细胞功能受损通过未折叠蛋白反应途径导致子痫前期

SCIENTIFIC REPORTS

IF3.9

2021-09-1641

OAAI

TETology: Epigenetic Mastermind in Action

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2021-03-1027

PREAI

Exploring the Role of Gut Microbiome in Colon Cancer

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2021-01-2589

PREAI

Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions - An in-silico study

与滋养层功能相关蛋白质的潜在SARS-CoV-2相互作用-一项计算机研究

PLACENTA

IF2.5

2021-01-0126

OAAI

Ruby Dhar

个人简介

教育背景

工作经历

荣誉奖项

研究方向